88 related articles for article (PubMed ID: 22006193)
1. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.
Li HJ; Wang W; Qu GL; Li YZ; Tao YH; Xing YT; Wang XT; Dai Y; Wei JY; Dai JR; Coles GC; Liang YS
Parasitol Res; 2012 May; 110(5):1727-32. PubMed ID: 22006193
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity of aryl ozonides against Schistosoma species.
Keiser J; Ingram K; Vargas M; Chollet J; Wang X; Dong Y; Vennerstrom JL
Antimicrob Agents Chemother; 2012 Feb; 56(2):1090-2. PubMed ID: 22106214
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintic activity in vivo of epiisopiloturine against juvenile and adult worms of Schistosoma mansoni.
Guimarães MA; de Oliveira RN; Véras LM; Lima DF; Campelo YD; Campos SA; Kuckelhaus SA; Pinto PL; Eaton P; Mafud AC; Mascarenhas YP; Allegretti SM; de Moraes J; Lolić A; Verbić T; Leite JR
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003656. PubMed ID: 25816129
[TBL] [Abstract][Full Text] [Related]
4. Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
Keiser J; Chollet J; Xiao SH; Mei JY; Jiao PY; Utzinger J; Tanner M
PLoS Negl Trop Dis; 2009; 3(1):e350. PubMed ID: 19125172
[TBL] [Abstract][Full Text] [Related]
5. Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.
Corrêa Soares JB; Menezes D; Vannier-Santos MA; Ferreira-Pereira A; Almeida GT; Venancio TM; Verjovski-Almeida S; Zishiri VK; Kuter D; Hunter R; Egan TJ; Oliveira MF
PLoS Negl Trop Dis; 2009 Jul; 3(7):e477. PubMed ID: 19597543
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice.
Li HJ; Wang W; Tao YH; Qu GL; Xing YT; Li YZ; Wei JY; Dai JR; Liang YS
Ann Trop Med Parasitol; 2011 Jun; 105(4):329-33. PubMed ID: 21871170
[No Abstract] [Full Text] [Related]
7. Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni.
Cowan N; Keiser J
Parasit Vectors; 2015 Aug; 8():417. PubMed ID: 26265386
[TBL] [Abstract][Full Text] [Related]
8. Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.
Sundaraneedi MK; Tedla BA; Eichenberger RM; Becker L; Pickering D; Smout MJ; Rajan S; Wangchuk P; Keene FR; Loukas A; Collins JG; Pearson MS
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006134. PubMed ID: 29240773
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a Single Oral Dose of Artesunate plus Sulfalene-Pyrimethamineversus Praziquantel in the Treatment of Schistosoma mansoni in Kenyan Children: An Open-Label, Randomized, Exploratory Trial.
Muok EMO; Were VO; Obonyo CO
Am J Trop Med Hyg; 2024 Apr; 110(4):677-680. PubMed ID: 38460198
[TBL] [Abstract][Full Text] [Related]
10. Antischistosomal activities of mefloquine-related arylmethanols.
Ingram K; Ellis W; Keiser J
Antimicrob Agents Chemother; 2012 Jun; 56(6):3207-15. PubMed ID: 22470113
[TBL] [Abstract][Full Text] [Related]
11.
Ammar AI; Afifi AF; Essa A; Galal-Khallaf A; Mokhtar MM; Shehab-Eldeen S; Rady AA
Infect Drug Resist; 2020; 13():3469-3484. PubMed ID: 33116667
[TBL] [Abstract][Full Text] [Related]
12. Dual Strategy to Design New Agents Targeting
Fuchs N; Zimmermann RA; Schwickert M; Gunkel A; Zimmer C; Meta M; Schwickert K; Keiser J; Haeberli C; Kiefer W; Schirmeister T
ACS Infect Dis; 2024 May; 10(5):1664-1678. PubMed ID: 38686397
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with
Tedla BA; Pickering D; Becker L; Loukas A; Pearson MS
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260125
[TBL] [Abstract][Full Text] [Related]
14. Robenidine derivatives as potential antischistosomal drug candidates.
Lotz CN; Krollenbrock A; Imhof L; Riscoe M; Keiser J
Int J Parasitol Drugs Drug Resist; 2024 May; 25():100546. PubMed ID: 38733883
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates.
d'Orchymont F; Hess J; Panic G; Jakubaszek M; Gemperle L; Keiser J; Gasser G
Medchemcomm; 2018 Nov; 9(11):1905-1909. PubMed ID: 30568758
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore Virtual Screening Identifies Riboflavin as an Inhibitor of the Schistosome Cathepsin B1 Protease with Antiparasitic Activity.
Cogo RM; Pavani TFA; Mengarda ACA; Cajas RA; Teixeira TR; Fukui-Silva L; Sun YU; Liu LJ; Amarasinghe DK; Yoon MC; Santos-Filho OA; de Moraes J; Caffrey CR; G G Rando D
ACS Omega; 2024 Jun; 9(23):25356-25369. PubMed ID: 38882094
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of dihydroartemisinin against Schistosoma mansoni schistosomula in mice.
Li HJ; Wang W; Li YZ; Qu GL; Xing YT; Qian K; Jia Y; Yang ZK; Qian YL; Dai JR; Liang YS
Southeast Asian J Trop Med Public Health; 2013 May; 44(3):379-87. PubMed ID: 24050069
[TBL] [Abstract][Full Text] [Related]
18. Modulation of mice immune responses against Schistosoma mansoni infection with anti-schistosomiasis drugs: Role of interleukin-4 and interferon-gamma.
Sharaf OF; Ahmed AA; Ibrahim AF; Shariq A; Alkhamiss AS; Alghsham R; Althwab SA; Alghaniam SA; Alhumaydhi FA; Alghamdi R; Alshomar A; Alabdullatif T; Alkhulayfi A; Alghunaim AA; Abdulmonem WA
Int J Health Sci (Qassim); 2022; 16(2):3-11. PubMed ID: 35300269
[TBL] [Abstract][Full Text] [Related]
19. Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity.
Guimarães MA; de Oliveira RN; de Almeida RL; Mafud AC; Sarkis ALV; Ganassin R; da Silva MP; Roquini DB; Veras LM; Sawada TCH; Ropke CD; Muehlmann LA; Joanitti GA; Kuckelhaus SAS; Allegretti SM; Mascarenhas YP; de Moraes J; Leite JRSA
PLoS One; 2018; 13(5):e0196667. PubMed ID: 29750792
[TBL] [Abstract][Full Text] [Related]
20. Natural products as leads in schistosome drug discovery.
Neves BJ; Andrade CH; Cravo PV
Molecules; 2015 Jan; 20(2):1872-903. PubMed ID: 25625682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
